Titan Pharmaceuticals, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Other Share Increase (Decrease) in Period, Weighted Average Exercise Price

Titan Pharmaceuticals, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Other Share Increase (Decrease) in Period, Weighted Average Exercise Price

Titan Pharmaceuticals, Inc. reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Other Share Increase (Decrease) in Period, Weighted Average Exercise Price of $0.00 per share for the 12-month period ending 2018-12-31, per its 10-K/A filed 2019-04-02.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice · last filed 2019-04-02

• Titan Pharmaceuticals, Inc. share-based compensation arrangements by share-based payment award, options, other share increase (decrease) in period, weighted average exercise price for fiscal 2018 was $0.00.
• Titan Pharmaceuticals, Inc. share-based compensation arrangements by share-based payment award, options, other share increase (decrease) in period, weighted average exercise price for fiscal 2016 was $0.00.